Clinical Trial

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2018-11-08; most recent amendment 2026-03-31.
Status change: Recruiting → Active, Not Recruiting 2023-07-23
Status change: Not Yet Recruiting → Recruiting 2019-01-08
Trial Details
NCT Number NCT03737734
Lead Sponsor Alpha Tau Medical LTD.
Conditions Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Enrollment 30 participants
Start Date 2018-12-31
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-06